Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 28;6(3):48-55.
doi: 10.4329/wjr.v6.i3.48.

Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review

Salvatore Annunziata  1 , Carmelo Caldarella  1 , Giorgio Treglia  1
Affiliations

Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review

Salvatore Annunziata et al. World J Radiol. .

Abstract

Aim: To systematically review published data on the cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography (FDG-PET) or PET/computed tomography (PET/CT) in tumours other than lung cancer.

Methods: A comprehensive literature search of studies published in PubMed/MEDLINE, Scopus and Embase databases through the 10(th) of October in 2013 was carried out. A search algorithm based on a combination of the terms: (1) "PET" or " PET/computed tomography (PET/CT)" or "positron emission tomography"; and (2) "cost-effectiveness" or "cost-utility" or "cost-efficacy" or "technology assessment" or "health technology assessment" was used. Only cost-effectiveness or cost-utility analyses in English language were included. Exclusion criteria were: (1) articles not within the field of interest of this review; (2) review articles, editorials or letters, conference proceedings; and (3) outcome evaluation studies, cost studies or health technology assessment reports. For each included study, information was collected concerning basic study, type of tumours evaluated, perspective/type of study, results, unit and comparison alternatives.

Results: Sixteen studies were included. Head and neck tumours were evaluated in 4 articles, lymphoma in 4, colon-rectum tumours in 3 and breast tumours in 2. Only one article was retrieved for melanoma, oesophagus and ovary tumours. Cost-effectiveness results of FDG-PET or PET/CT ranged from dominated to dominant.

Conclusion: Literature evidence about the cost-effectiveness of FDG-PET or PET/CT in tumours other than lung cancer is still limited. Nevertheless, FDG-PET or PET/CT seems to be cost-effective in selective indications in oncology (staging and restaging of head and neck tumours, staging and treatment evaluation in lymphoma).

Keywords: Cost-effectiveness; Fluorine-18-Fluorodeoxyglucose; Oncology; Positron emission tomography; Positron emission tomography /computed tomography.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the systematic review. FDG-PET: Fluorine-18-Fluorodeoxyglucose positron emission tomography.
See this image and copyright information in PMC

References

    1. Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics (first part) Ital J Med. 2010;4:84–91.
    1. Salvatori M, Oradei M. Economic evaluation of nuclear medicine procedures. Eur J Nucl Med Mol Imaging. 2010;37:1786–1792. - PubMed
    1. Yang Y, Czernin J. Contribution of imaging to cancer care costs. J Nucl Med. 2011;52 Suppl 2:86S–92S. - PubMed
    1. Langer A. A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner? BMC Health Serv Res. 2010;10:283. - PMC - PubMed
    1. Cao JQ, Rodrigues GB, Louie AV, Zaric GS. Systematic review of the cost-effectiveness of positron-emission tomography in staging of non--small-cell lung cancer and management of solitary pulmonary nodules. Clin Lung Cancer. 2012;13:161–170. - PubMed

LinkOut - more resources